drugset / Trial / NCT02557386

Optimal Volume of Bupivacaine in Adductor Canal Nerve Block

NCT02557386

Phase 4 Unknown 60 enrolled Pontificia Universidad Catolica de Chile
RandomizedParallel-groupDouble-blindTreatment

Summary

To establish adequate volume of levobupivacaine 0.25% in adductor canal nerve block in unilateral cruciate ligament of the knee reconstruction surgery.

Timeline

Start
2016-01
Primary completion
2016-12
Completion
2017-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Levobupivacaine Other / unclassified 5 ml Other
Subject Levobupivacaine Other / unclassified 10 ml Other
Subject Levobupivacaine Other / unclassified 15 ml Other
Subject Levobupivacaine Other / unclassified 20 ml Other
Subject Levobupivacaine Other / unclassified 25 ml Other
Subject Levobupivacaine Other / unclassified 30 ml Other

Indications

No indication recorded.